Skip to main content
. 2009 Aug;63(8):1198–1204. doi: 10.1111/j.1742-1241.2009.02108.x

Figure 1.

Figure 1

Occurrence of dry mouth (A), constipation (B), headache (C), nausea (D), urinary tract infection (E), blurred vision (F), dry eye (G), dizziness (H) and micturition disorder (I) by treatment and age group. TOL ER, tolterodine extended release